- Health Canada DPD: MANERIX (BAUSCH HEALTH, CANADA INC., DIN 02166747) · product monograph (PDF)
- Health Canada DPD: MOCLOBEMIDE (AA PHARMA INC, DIN 02232148) · product monograph (PDF)
- Spain CIMA (Spanish): search for “moclobemida” (external search; text not reproduced)
Links only. These regulators' terms do not clearly permit reproducing the documents, so no text is shown here. Check the Philippine package insert in the products table.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Film-coated tablet: 150 mg
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Moclobemide as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
AurorixMoclobemide | 150 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10’s Box of 100’s | Rx | CenexiFrance | Importer: A. Menarini Philippines, Inc.Trader: MEDA Pharma GmbH & Co. KG | DR-XY42634 | Sep 16, 2028 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .